Jessica is a regulatory expert with 17 years of experience in rare and common disease indications, including pulmonary, immunology, neurology, inflammation, and oncology. She provides strategic advice, submissions support, and due diligence services for small molecule, biologic, and cell and gene therapy development programs and has directed the preparation of global health authority interactions. Jessica has facilitated global regulatory activities through her own consultancy Gaia Regulatory Sciences, LLC, NovusLife (a rare disease and oncology focused consulting firm), Voisin Consulting Life Sciences, and Takeda Pharmaceuticals. She also managed clinical trial submissions for PAREXEL, and the Dana Farber Cancer Institute. Jessica holds a bachelor’s degree in Psychology from the University of New Hampshire, a master’s degree in Regulatory Affairs from Northeastern University, and Regulatory Affairs Certification (RAC).